<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Eris Lifesciences Limited — News on 6ix</title>
    <link>https://6ix.com/company/eris-lifesciences-limited</link>
    <description>Latest news and press releases for Eris Lifesciences Limited on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Fri, 20 Mar 2026 20:08:53 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/eris-lifesciences-limited" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68364b5978dffbe2df15346a.webp</url>
      <title>Eris Lifesciences Limited</title>
      <link>https://6ix.com/company/eris-lifesciences-limited</link>
    </image>
    <item>
      <title>Press Release Mar 20 2026</title>
      <link>https://6ix.com/company/eris-lifesciences-limited/news/press-release-mar-20-2026-4</link>
      <guid isPermaLink="true">https://6ix.com/company/eris-lifesciences-limited/news/press-release-mar-20-2026-4</guid>
      <pubDate>Fri, 20 Mar 2026 20:08:53 GMT</pubDate>
      <description>Eris Lifesciences Limited has informed the Exchange regarding a press release dated March 20, 2026, &quot;Launch of Generic Semaglutide under the Brand &quot;Sundae&quot; in India.&quot;.</description>
    </item>
    <item>
      <title>Press Release Feb 24 2026</title>
      <link>https://6ix.com/company/eris-lifesciences-limited/news/press-release-feb-24-2026-4</link>
      <guid isPermaLink="true">https://6ix.com/company/eris-lifesciences-limited/news/press-release-feb-24-2026-4</guid>
      <pubDate>Tue, 24 Feb 2026 17:09:58 GMT</pubDate>
      <description>Eris Lifesciences Limited has informed the Exchange regarding a press release dated February 24, 2026, titled &quot;Eris Lifesciences Ltd Announces Strategic Partnership with Natco Pharma Ltd for Semaglutide Launch in India&quot;.</description>
    </item>
    <item>
      <title>Press Release Aug 26 2025</title>
      <link>https://6ix.com/company/eris-lifesciences-limited/news/press-release-aug-26-2025-5</link>
      <guid isPermaLink="true">https://6ix.com/company/eris-lifesciences-limited/news/press-release-aug-26-2025-5</guid>
      <pubDate>Tue, 26 Aug 2025 15:50:12 GMT</pubDate>
      <description>Eris Lifesciences Limited has informed the Exchange regarding a press release dated August 26, 2025, titled &quot;Eris Lifesciences Receives ANVISA approval for Sterile Injectable Facility&quot;.</description>
    </item>
    <item>
      <title>Press Release Aug 25 2025</title>
      <link>https://6ix.com/company/eris-lifesciences-limited/news/press-release-aug-25-2025-7</link>
      <guid isPermaLink="true">https://6ix.com/company/eris-lifesciences-limited/news/press-release-aug-25-2025-7</guid>
      <pubDate>Mon, 25 Aug 2025 15:44:38 GMT</pubDate>
      <description>Eris Lifesciences Limited has informed the Exchange regarding a press release dated August 25, 2025, titled &quot;Eris Lifesciences Receives ANVISA approval at its Ahmedabad campus&quot;.</description>
    </item>
    <item>
      <title>Press Release Mar 14 2024</title>
      <link>https://6ix.com/company/eris-lifesciences-limited/news/press-release-mar-14-2024-9</link>
      <guid isPermaLink="true">https://6ix.com/company/eris-lifesciences-limited/news/press-release-mar-14-2024-9</guid>
      <pubDate>Thu, 14 Mar 2024 19:32:42 GMT</pubDate>
      <description>Eris Lifesciences Limited has informed the Exchange regarding a press release dated March 14, 2024, titled &quot;Eris Lifesciences acquires the commercial rights to Biocon Biologics  India Branded Formulations business; both organisations enter into a long- term collaboration to expand patient access in India.&quot;.</description>
    </item>
    <item>
      <title>Press Release Nov 08 2023</title>
      <link>https://6ix.com/company/eris-lifesciences-limited/news/press-release-nov-08-2023-12</link>
      <guid isPermaLink="true">https://6ix.com/company/eris-lifesciences-limited/news/press-release-nov-08-2023-12</guid>
      <pubDate>Wed, 08 Nov 2023 21:34:51 GMT</pubDate>
      <description>Eris Lifesciences Limited has informed the Exchange regarding a press release dated November 08, 2023, titled &quot;Eris announces the acquisition of Nephrology and Dermatology Branded Formulations business units of Biocon Biologics in India&quot;.</description>
    </item>
  </channel>
</rss>